SNGX
SoligenixยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
SNGX Profile
Soligenix, Inc.
A late-stage biopharmaceutical company
29 Emmons Drive, Suite B-10, Princeton, NJ 08540
--
Founded in 1987, Soligenix, Inc., is a clinical-stage biopharmaceutical company focused on the development of products for the treatment of life-threatening side effects (still an unmet medical need) arising from the treatment of cancer and serious gastrointestinal diseases, as well as the development of a variety of biodefense vaccines and therapies.
